Table 3—

Main clinical features and glucose parameters according to treatment in 371 outpatients with non–insulin-treated type 2 diabetes

DietMETSUMET + SUP
Sex (% men)796554540.06
Age (years)60 ± 2.057 ± 1.462 ± 0.759 ± 0.90.08
Duration of diabetes (years)5.3 ± 1.26.7 ± 1.17.7 ± 0.49.4 ± 0.60.009
BMI (kg/m2)29.0 ± 0.929.7 ± 0.827.8 ± 0.329.5 ± 0.50.005
HbA1c (%)5.8 ± 0.26.0 ± 0.36.4 ± 0.17.2 ± 0.2<0.0001
Prebreakfast PG (mmol/l)6.5 ± 0.27.8 ± 0.37.8 ± 0.18.9 ± 0.2<0.001
Postbreakfast PG (mmol/l)7.9 ± 0.58.9 ± 0.59.9 ± 0.211.5 ± 0.3<0.001
Prelunch PG (mmol/l)7.7 ± 0.46.9 ± 0.37.8 ± 0.29.4 ± 0.3<0.001
Postlunch PG (mmol/l)8.1 ± 0.48.6 ± 0.59.7 ± 0.211.3 ± 0.3<0.001
Predinner PG (mmol/l)6.1 ± 0.26.9 ± 0.37.3 ± 0.28.7 ± 0.3<0.001
Δ PG breakfast (mmol/l)1.3 ± 0.41.1 ± 0.32.1 ± 0.22.6 ± 0.30.009
Δ PG lunch (mmol/l)1.4 ± 0.31.6 ± 0.41.9 ± 0.21.9 ± 0.30.719
  • Data are means ± SEM. P values were derived from analysis of variance or χ2. MET, metformin; PG, plasma glucose; SU, sulphonylureas.